共 94 条
[21]
Wermers R(2004)Pancreatic endocrine tumors J Surg Res 120 139-85
[22]
Fatourechi V(2007)Nuclear imaging of neuroendocrine tumours Best Pract Res, Clin Endocrinol Metab 21 69-4663
[23]
Wynne A(1999)Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome J Clin Oncol 17 600-866
[24]
Kvols L(2009)Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group J Clin Oncol 27 4656-86
[25]
Lloyd R(2003)Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors Arch Surg 138 859-1505
[26]
Stacpoole PW(2010)Advances in the treatment of gastroenteropancreatic neuroendocrine tumors Clin Exp Gastroenterol 3 79-513
[27]
Alexander EK(2011)Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies Oncogene 30 1497-undefined
[28]
Robinson M(2011)Sunitinib malate for the treatment of pancreatic neuroendocrine tumors N Engl J Med 364 501-undefined
[29]
Staniec M(undefined)undefined undefined undefined undefined-undefined
[30]
Dluhy RG(undefined)undefined undefined undefined undefined-undefined